Reading this on a mobile device? Try our optimized mobile version here:

October 17, 2012
Sign upForwardArchiveAdvertise
News for and about dermatologic surgeons

  Healthy, Beautiful Skin 
  • Other docs choose dermatologists for skin cancer, cosmetic procedures
    Primary care physicians say dermatologists are more qualified than plastic surgeons or otolaryngologists to evaluate and biopsy facial lesions, excise skin cancer, inject botulinum toxin and fillers, and conduct laser procedures, according to a survey in the journal Dermatologic Surgery. "The data reflect the leading role that dermatologists have played in developing and improving many of these procedures," said lead author and dermatologist Omar Ibrahimi, an assistant professor of dermatology, dermatologic surgery and Mohs surgery at the University of Connecticut Health Center. Medscape (free registration) (10/16) LinkedInFacebookTwitterEmail this Story
  • Study IDs risk factors for nonmelanoma skin cancer extension
    Lesion location and preoperative size, patient age and immunosuppression are risk factors for the aggressive subclinical extension of nonmelanoma skin cancer, according to a study presented at the Annual Meeting of the American Society for Dermatologic Surgery. Lesions on the ear, nasal labial fold, cheek, eyebrow, neck, eyelid or lip were at higher risk of being larger under the surface than on the surface, as were 20 to 30 millimeter tumors. Lung transplant patients were at significantly increased risk for lesions with ASE, but other transplants, including transplants of hearts, did not carry an increased risk. Medscape (free registration) (10/16) LinkedInFacebookTwitterEmail this Story
  • FDA tells Avon to tone down claims on anti-wrinkle products
    The FDA warned Avon that the cosmetic manufacturer's claims regarding its Anew Clinical Advanced Wrinkle Corrector and other products make the products sound like drugs that should be subject to FDA approval. Claims that the products have an effect on cells and skin repair processes "indicate that these products are intended to affect the structure or any function of the human body, rendering them drugs," the FDA officials wrote in a letter. Reuters (10/16), The Wall Street Journal (10/16) LinkedInFacebookTwitterEmail this Story
Looking to expand your options for treatment?
When your choice for treating dermatologic condition is a custom-compounded medication, turn to Wedgewood Pharmacy. You can rely on us to provide more choices, consistency quality and world-class customer care. We offer an array of pharmaceutical and natural options, such as Benzocaine/Lidocaine/Tetracaine in Vani-Cream to help meet your patients' needs. Receive FREE STANDARD SHIPPING through November 30th with promo code RN8990.
  Tools of the Trade 
  • Study compares suture techniques for trunk and extremities
    Subcuticular closure of linear wounds on the trunk and extremities produces better cosmetic outcomes than simple interrupted or simple running sutures, according to a literature review presented at the American Society for Dermatologic Surgery's Annual Meeting. Healio (10/16) LinkedInFacebookTwitterEmail this Story
  • Researchers seek new treatment for acne
    The bacteria that cause acne are increasingly resistant to topical and oral antibiotics, leaving researchers scrambling to find alternatives. Researchers at the University of California at Los Angeles, the University of Pittsburgh, Rockefeller University and elsewhere are using genetic analyses to program harmless viruses, or bacteriophages, that live on the skin to kill the bacteria that cause acne. National Public Radio (text and audio)/Shots blog (10/15), Bloomberg (10/10) LinkedInFacebookTwitterEmail this Story
  • Lawmakers call for greater FDA oversight of compounding pharmacies
    In response to an outbreak of fungal meningitis linked to steroid injections, Reps. Rosa DeLauro, D-Conn., and Edward Markey, D-Mass., said that they will draft legislation to give the FDA greater authority over compounded drugs. Markey said the agency should be able to prohibit compounding pharmacies from using ingredients that do not have FDA approval, and his legislation would require the businesses to report safety problems to the government. Yahoo/The Associated Press (10/9) LinkedInFacebookTwitterEmail this Story
  • Dermatologic surgeons call for greater oversight: ASDS is asking federal and state regulatory authorities to re-examine their oversight and enforcement of compounding pharmacies. Learn more. LinkedInFacebookTwitterEmail this Story
  • Other News
  Perfecting Your Practice 
  • Data reveal uptick in physician office visits
    Primary care visits from patients with insurance reached 12.7 patients per day in the third quarter of 2012, compared with 12.4 per day during the same period last year, while visits to specialists also inched up, according to Truven Health Analytics. Accountable care organizations, patient-centered medical homes, and other federal and private initiatives designed to improve health care and curb costs may explain the uptick, a Truven official said. American Medical News (free content) (10/15) LinkedInFacebookTwitterEmail this Story
  ASDS News 

Learn more about ASDS ->Find a dermatologic surgeon | Why choose a dermatologic surgeon? | Join ASDS

In times of change, learners inherit the earth; while the learned find themselves beautifully equipped to deal with a world that no longer exists."
--Eric Hoffer,
American social writer

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Sales Associate:  Jasmine Rogers (202) 640-4684
A powerful website for SmartBrief readers including:
 Recent ASDS Skin Source SmartBrief Issues:   Lead Editor:  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information